Literature DB >> 15130257

Adherence to oral therapies in pelvic inflammatory disease.

Jacqueline Dunbar-Jacob1, Susan M Sereika, Susan M Foley, Debra C Bass, Roberta B Ness.   

Abstract

PURPOSE: To assess adherence to oral therapies in pelvic inflammatory disease (PID).
METHODS: Medication adherence to oral doxycycline therapy (100 mg) was measured using electronic event monitoring (EEM) among adult women with PID. Subjects (n = 91), who were predominantly black and with a high school or lower educational attainment, were randomly selected from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Study, a trial in which subjects were randomized to either (1). initial inpatient then outpatient or (2). fully outpatient treatment with doxycycline and cefoxitin. Summary statistics calculated within treatment groups and in the cohort as a whole included the percentage of administrations taken, percentage of days with correct dosage, percentage of days with no drug taken, time elapsed until the first drug holiday, and percentage of optimal dosing intervals.
RESULTS: Study subjects took an average of 70% of prescribed doses, took the prescribed two daily doses for less than half of their outpatient days, took an unscheduled drug holiday for almost 25% of their outpatient days, and took only 16.9% of their doses within the optimal timing interval. In general, working, not bleeding with sex, and not drinking hard liquor were positively associated with measures of adherence. Adherence estimates were similar among women in the inpatient and outpatient groups after hospital discharge.
CONCLUSIONS: The disturbing rates of time interval adherence, even after hospitalization, suggest the need to determine the effectiveness of antibiotic regimens involving shorter courses and longer dosing intervals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130257     DOI: 10.1089/154099904323016446

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  14 in total

1.  Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients.

Authors:  Cynthia Russell; Vicki Conn; Catherine Ashbaugh; Richard Madsen; Mark Wakefield; Andrew Webb; Deanna Coffey; Leanne Peace
Journal:  Clin Transplant       Date:  2010-11-16       Impact factor: 2.863

2.  Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.

Authors:  J D C Ross; H S Cronjé; T Paszkowski; I Rakoczi; D Vildaite; A Kureishi; M Alefelder; P Arvis; P Reimnitz
Journal:  Sex Transm Infect       Date:  2006-05-24       Impact factor: 3.519

3.  Azithromycin for PID beats doxycycline on all counts.

Authors:  Kate Rowland; Bernard Ewigman
Journal:  J Fam Pract       Date:  2007-12       Impact factor: 0.493

Review 4.  Self-management interventions in stages 1 to 4 chronic kidney disease: an integrative review.

Authors:  Janet L Welch; Michelle Johnson; Lani Zimmerman; Cynthia L Russell; Susan M Perkins; Brian S Decker
Journal:  West J Nurs Res       Date:  2014-09-18       Impact factor: 1.967

5.  Adverse adolescent reproductive health outcomes after pelvic inflammatory disease.

Authors:  Maria Trent; Catherine L Haggerty; Jacky M Jennings; Sunghee Lee; Debra C Bass; Roberta Ness
Journal:  Arch Pediatr Adolesc Med       Date:  2011-01

6.  Is It Time to Stop Using Single-dose Oral Metronidazole for the Treatment of Trichomoniasis in Women?

Authors:  Christina A Muzny; Saralyn Richter; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2019-05       Impact factor: 2.830

7.  Management of Pelvic Inflammatory Disease in Selected U.S. Sexually Transmitted Disease Clinics: Sexually Transmitted Disease Surveillance Network, January 2010-December 2011.

Authors:  Eloisa Llata; Kyle T Bernstein; Roxanne P Kerani; Preeti Pathela; Jane R Schwebke; Christina Schumacher; Mark Stenger; Hillard S Weinstock
Journal:  Sex Transm Dis       Date:  2015-08       Impact factor: 2.830

Review 8.  Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment.

Authors:  Caroline Mitchell; Malavika Prabhu
Journal:  Infect Dis Clin North Am       Date:  2013-10-31       Impact factor: 5.982

Review 9.  Improving adherence to guidelines for the diagnosis and management of pelvic inflammatory disease: a systematic review.

Authors:  Bette Liu; Basil Donovan; Jane S Hocking; Janet Knox; Bronwyn Silver; Rebecca Guy
Journal:  Infect Dis Obstet Gynecol       Date:  2012-08-29

10.  Patient Satisfaction and Treatment Adherence for Urban Adolescents and Young Adults with Pelvic Inflammatory Disease.

Authors:  Jennifer Anders; Alexandra Hill; Shang-En Chung; Arlene Butz; Richard Rothman; Charlotte Gaydos; Jamie Perin; Maria Trent
Journal:  Trauma Emerg Care       Date:  2017-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.